Ranbaxy to develop anti-infective drugs for Merck
LONDON, May 12 (Reuters) - India's Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research, Stock Buzz) has signed a deal to develop new anti-infective drugs for U.S.-based Merck & Co Inc (MRK.N: Quote, Profile, Research, Stock Buzz), underlining the growing use of Indian research by multinational companies.
Ranbaxy will carry out drug discovery and clinical development through Phase IIa clinical trials, with Merck responsible for later development and commercialisation, the companies said in a statement on Monday. (Reporting by Ben Hirschler)
© Thomson Reuters 2008 All rights reserved
Ads by Career Builder
Medical & Healthcare Opportunities
Details: ...in life. Medical / Healthcare Some of the opportunities...in the Medical and Healthcare area include: Dental...
Healthcare Auditor (NYC or Melville)
Details: ...Senior Associates to join our Healthcare group in our New York City...audit engagements of various healthcare clients * Participate in the...
Healthcare Coordinator Nurse / RN
Details: Position:Healthcare Coordinator Healthcare Coordinators are...family atmosphere. Healthcare Coordinator duties...
Director of Case Management -Healthcare -Wisconsin
Details: ...Case Management -Healthcare -Hospital Director of Case Management -Healthcare -Wisconsin Are...Case Management -Healthcare -Wisconsin position...
iPhone fix
Obama hopes for convention bounce
